New Hepatitis C

Fueled in part by the opioid epidemic the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount new therapies have produced seismic changes in how HCV is treated clinically leaving a gap between the most current clinical guidance and the ongoing demands of patient care. <p/><em>The New Hepatitis C</em> is a current and essential review of HCV's epidemiology diagnosis and clinical approaches -- a clinician's guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed as are important new treatment options for HCV management of side effects and a convenient summary of clinical trials on the treatment of chronic hepatitis C. <p/>Updated to detail the standards of care that will define the next decade of HCV management this evidence-based volume is an essential clinical reference for to any practitioner in gastroenterology hepatology infectious disease transplant or internal medicine.<br>